| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $6,878,293 ) |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | DP2AI154410 | Revealing the Biophysics of the Germinal Center Microenvironment | 000 | 5 | NIH | 12/3/2025 | $480,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21NS140036 | Utilizing a novel hamster model to determine neurologic and behavioral abnormalities of offspring from mothers infected with SARS-CoV-2 | 000 | 2 | NIH | 12/18/2025 | $200,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 000 | 4 | NIH | 12/9/2025 | $388,626 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM130326 | Dynamics of DNA scanning and recognition by proteins | 000 | 8 | NIH | 1/27/2026 | $482,400 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI183177 | Identification of diagnostic biomarkers for flea-borne typhus | 000 | 2 | NIH | 1/10/2026 | $200,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH134761 | Targeting cell-to-cell communication to prevent bystander damage mediated by viral reservoirs | 000 | 3 | NIH | 1/27/2026 | $689,960 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH132226 | Probing brain circuit and behavior with protein:protein interaction modulators | 000 | 4 | NIH | 12/10/2025 | $794,232 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03AI182562 | Development of a latex-agglutination assay for the rapid detection of Naegleria fowleri | 000 | 2 | NIH | 12/3/2025 | $80,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS140424 | Sculpting Membrane Dynamics: Membrane-Remodeling Factors Shape Oligodendroglial Form and Function | 000 | 2 | NIH | 1/26/2026 | $412,371 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH077303 | Synaptic Organizers: Dynamic Regulation of Trans-synaptic Bridges | 000 | 19 | NIH | 12/16/2025 | $737,907 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK132072 | Targeting bone marrow to treat renal disease | 000 | 4 | NIH | 1/8/2026 | $468,449 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 5 | NIH | 12/2/2025 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI187192 | Investigation of RNA packaging in Rift Valley fever virus | 000 | 2 | NIH | 12/5/2025 | $655,774 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG097537 | Microglia and Tau Oligomer Polymorphs Interplay in Cognitive Resilience in Alzheimers disease | 000 | 1 | NIH | 12/23/2025 | $548,723 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AI179997 | Generation of Orientia tsutsugamushi mutant strains for pathogenesis research | 000 | 3 | NIH | 1/13/2026 | $275,062 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 000 | 4 | FDA | 1/28/2026 | $400,000 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24AG072458 | Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias | 000 | 5 | NIH | 12/17/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R33AG078519 | Developing, Implementing, and Evaluating a Caregiver and Elder Abuse Screening, Risk Assessment and Treatment to Improve Outcomes for Older and Vulnerable Adults with MCI/ADRD | 001 | 3 | NIH | 1/23/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R33AG078519 | Developing, Implementing, and Evaluating a Caregiver and Elder Abuse Screening, Risk Assessment and Treatment to Improve Outcomes for Older and Vulnerable Adults with MCI/ADRD | 000 | 3 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI176297 | Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases | 000 | 2 | NIH | 12/2/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21DA063306 | GPR6: A Circuit-Level Druggable Target in Cocaine Use Disorder | 000 | 1 | NIH | 11/20/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY037126 | The Role of mtDNA/ZBP1 in Retinal Neurodegeneration | 000 | 1 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA040621 | Small molecule modulators of ΔFosB | 000 | 10 | NIH | 1/26/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01CE003772 | CE25-021 - Rise Up! A Youth-Informed Video Program To Prevent Community Violence Before The First Shot | 01 | 1 | CDC | 12/21/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | P01AI150585 | Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus | 000 | 5 | NIH | 1/26/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | P30AG059301 | The Texas Resource Center on Minority Aging Research (RCMAR) | 000 | 8 | NIH | 12/18/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW010331 | Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses | 000 | 10 | NIH | 12/8/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW010331 | Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses | 000 | 10 | NIH | 12/8/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21EB034033 | White matter tract-specific near-infrared fluorescence probes for in vivo fluorescence guided white matter tractography | 000 | 3 | NIH | 12/15/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI146227 | Mechanistic function of HCV NS5A targeted by the potent inhibitors | 000 | 5 | NIH | 11/24/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00HL153678 | Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis | 001 | 5 | NIH | 1/5/2026 | $77,350 |
| | 2026 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00HL153678 | Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis | 000 | 5 | NIH | 1/5/2026 | -$77,350 |
| | 2026 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21ES034956 | Brain derived extracellular vesicles-mediated neurotoxicity of deltamethrin | 000 | 1 | NIH | 11/20/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI147948 | Role of IL-17 Cytokine Networks in TB Relapse Due to HIV | 000 | 5 | NIH | 1/27/2026 | -$7,984 |
| | 2026 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00DC016328 | Determining the roles of Ca2+-binding proteins in modulation of hair cell mechanotransduction | 000 | 5 | NIH | 11/25/2025 | -$351 |
| | 2026 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K22AI159917 | Cathelicidin modulates the host response during fungal sepsis. | 000 | 2 | NIH | 1/16/2026 | -$2,327 |
| | 2026 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UG3NS128397 | Chronic Subdural Hematoma Treatment with Embolization vs Surgery or MedicalManagement Study (CHESS) | 000 | 1 | NIH | 1/16/2026 | $0 |
| | 2026 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG066060 | Role of Neuroprotective Indoles in Delaying the Onset of Cognitive Decline | 000 | 2 | NIH | 1/5/2026 | -$21 |
| | 2026 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI146353 | Markers of Triclabendazole Resistant Fascioliasis in the Highlands of Peru | 000 | 4 | NIH | 1/27/2026 | -$18,953 |
| | 2026 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | P01AI062885 | Epithelial innate signaling in airway inflammation and remodeling | 000 | 15 | NIH | 12/19/2025 | -$222 |
| | 2026 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK106229 | Hypothalamic-Striatal Control of Motivation for Obesogenic Food | 000 | 4 | NIH | 10/1/2025 | $0 |
| | 2026 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UG3DA052282 | NOP Receptor Antagonist for OUD Pharmacotherapy | 000 | 1 | NIH | 10/1/2025 | -$206,131 |
| | 2026 | 2019 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI125434 | Hydrogen Sulfide and NRF2 Cross-talk in Viral Infections | 000 | 3 | NIH | 10/1/2025 | -$99,221 |
|
| Issue Date FY: 2025 ( Subtotal = $93,683,368 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U3REP220679 | Regional Emerging Special Pathogen Treatment Center Cooperative Agreement | 01 | 3 | ASPR | 1/17/2025 | $2,000,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K23AG083231 | No time to pause: Physical activity to improve health and well-being of midlife Hispanic women during the menopausal transition | 000 | 2 | NIH | 7/28/2025 | $176,275 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK125730 | ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE | 000 | 5 | NIH | 2/28/2025 | $388,872 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG073133 | Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders | 000 | 5 | NIH | 7/11/2025 | $733,677 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK129474 | Evaluating telementoring to initiate a multidimensional diabetes program for Latino(a)s in community clinics: A Randomized Clinical Trial | 000 | 6 | NIH | 9/1/2025 | $572,989 |
|
